Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Top 6 worries about healthcare AI among clinicians and patients in 2026
AI is now as much a part of U.S. healthcare as any other technology category in wide use across the sector. However, like no other technology, its role is “being actively shaped, not passively adopted” by clinicians and patients alike.
Connection uncovered between liability protections and downsizing decisions—in nursing homes, at least
When nursing homes lose their fear of getting sued for substandard care quality, they tend to make do with fewer caregivers, a new study reveals.
FDA highlights recall of certain Impella introducer kits after 3 injuries
This latest recall was put in place due to an increased risk of blood clots developing during use. Only a small number of hospitals are affected.
Medical societies respond after Trump administration questioned necessity of certain procedures
A recent OIG report suggested vascular surgeons, interventional cardiologists and interventional radiologists may be performing medically unnecessary procedures in office-based labs. Now, some of the leading medical societies from those fields have provided additional context.
When used in the ‘wild’ conditions of the real world, large language AI stumbles
Asking medical questions of AI with language spoken “in the wild”—meaning with LLM prompts from everyday consumers—brings back answers with decidedly mediocre accuracy, a new study shows.

More than 17,000 medical devices used to diagnose and treat the lungs and airways are being recalled.

UCL Imaging vest screening cardiac conditions

New vest developed by cardiologists uses advanced heart imaging to screen for sudden cardiac arrest

“We identified a problem in cardiology,” one cardiologist explained. “Heart imaging has made remarkable progress in recent decades, but the electrics of the heart have eluded us."

Balloon-expandable TAVR valves linked to superior 1-year outcomes

Asian patients are rarely represented in large TAVR trials, the authors wrote, so they focused on nearly 1,200 patients from South Korea to provide a fresh perspective.

Hospital C-suites increasingly perceive need for digital health mission, vision

More than two-thirds of hospital executives, 70%, say their institution has a formal or comprehensive strategy in place for selecting, acquiring and integrating digital health products.

Newsweek ranked the 50 best heart hospitals in the world

Hybrid coronary revascularization vs. CABG for multivessel CAD: New meta-analysis tracks long-term outcomes

A hybrid approach may increase the risk of certain adverse events, according to a new meta-analysis focused on long-term outcomes.

Former FDA employees share concerns about heart device safety data

Abbott's HeartMate 3 LVAD is the only FDA-approved device of its kind currently available in the United States. Should reports of adverse events worry cardiologists? Or are they to be expected when treating such a vulnerable patient population?

‘A true breakthrough’: The eye-opening potential of GLP-1 agonists to treat heart, kidney disease in addition to obesity

While GLP-1 drugs were originally developed to treat diabetes, researchers keep finding additional ways these medications can potentially benefit patients.

What will it take to win consumer buy-in on GenAI for healthcare?

Americans aren’t OK with generative healthcare AI that was developed without physicians and is sold by vendors without track records.

Care Delivery

Top 6 worries about healthcare AI among clinicians and patients in 2026

Connection uncovered between liability protections and downsizing decisions—in nursing homes, at least

FDA highlights recall of certain Impella introducer kits after 3 injuries

Medical societies respond after Trump administration questioned necessity of certain procedures

When used in the ‘wild’ conditions of the real world, large language AI stumbles